Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Justin AC Powell
    Junior Member
    • Jun 2012
    • 5

    RNA-Seq quantitation for human, paired end vs single end, strand specific or not?

    Is there any consensus of opinion on the best RNA-Seq approach for quantitation of alternative splicing on well annotated genomes (e.g. human)? We don’t want to look for novel splice isoforms, we want to detect regulation of alternative splicing by our treatment among the annotated isoforms of a gene. For roughly the same price I can get:

    60M x 50 bp single end reads

    30M x 50bp paired end reads random primed cDNA

    30M x 125 bp paired end reads using strand specific cDNA library

    I guess in part this depends on the differential splicing analysis method chosen – something that counts only exon inclusion should work just as well with single ends. If you look for exon exclusion then you need reads that map across splice junctions, I don’t know if the chances of that are improved more by increasing the read length, or increasing the read depth (naively it would seem doubling either would have the same effect). Finally I don’t know what the benefit of strand specific libraries are for quantitation, one concern is that if they are more involved to produce then they might introduce variability - obviously in some cases they will help discriminate between sense and anti-sense transcripts from the same region.
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    'Of a gene'? A specific gene? How highly expressed?

    Ever considered the Iso-Seq PacBio protocol?

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      For reference (cross-posted): https://www.biostars.org/p/173399/

      Comment

      • Justin AC Powell
        Junior Member
        • Jun 2012
        • 5

        #4
        It's exploratory - so we're looking genome wide. Our vendor doesn't seem to recommend Iso-Seq for differential RNA expression but I haven't discussed why.

        Comment

        • danwiththeplan
          Member
          • Sep 2011
          • 72

          #5
          While trinity is obviously not relevant for humans, this vid explains strand specficity quite well:



          You will likely miss antisense transcription without it, or worse, mistake it for sense transcription, which could cause issues resolving isoforms?

          Comment

          • gringer
            David Eccles (gringer)
            • May 2011
            • 845

            #6
            No eukaryote genome is sufficiently annotated that novel isoforms won't be found in RNASeq data. Even if that were the case, some genes have fairly complex splice variants that benefit a lot from strand-specific sequencing. As an example, the transcriptome annotation shows genes that overlap with another gene on the opposite strand, and resolution of these genes will be impossible without strand-specific sequencing.

            Regardless, given the choice between "60M x 50 bp single end" and "30M x 125 bp anything", I would choose the longer reads. Even if it were single end, you're getting a higher coverage with the longer reads (60 * 50 vs 30 * 125).

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            25 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Working...